QQ客服 官方微博 反馈留言

	RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells
	Yang, XS; Pan, Y; Qiu, ZJ; Du, ZW; Zhang, Y; Fa, PY; Gorityala, S; Ma, SH; Li, SQ; Chen, CS
会议名称	CLINICAL CANCER RESEARCH
会议日期	2018
会议地点	1629-1643
会议录	Vol.24 No.7
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/5451253
专题	湖南大学
作者单位	1.Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH USA 2.Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, Guangzhou, Guangdong, Peoples R China 3.Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA 4.Washington Univ, Sch Med, Breast Oncol Sect, Div Oncol, St Louis, MO USA 5.Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China 6.Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA 7.Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA 8.Augusta Univ, Georgia Canc Ctr, Augusta, GA USA 9.Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA [ 10 ] China Med Univ, Canc Hosp, Dept Breast Surg & Plast Surg, Shenyang, Liaoning, Peoples R China [ 11 ] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA
推荐引用方式 GB/T 7714	Yang, XS,Pan, Y,Qiu, ZJ,et al. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells[C]. 见:CLINICAL CANCER RESEARCH. 1629-1643. 2018.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。